Literature DB >> 19762577

Investigation of two outbreaks of suspected oral transmission of acute Chagas disease in the Amazon region, Para State, Brazil, in 2007.

Henrique de Barros Moreira Beltrão1, Matheus de Paula Cerroni, Daniel Roberto Coradi de Freitas, Ana Yecê das Neves Pinto, Vera da Costa Valente, Sebastião Aldo Valente, Elenild de Góes Costa, Jeremy Sobel.   

Abstract

Acute Chagas disease (ACD) is caused by Trypanosoma cruzi. ACD outbreaks due to probable oral transmission occur regularly in small family gatherings that are exposed to contaminated foods. We studied two cohorts of residents on islands in the Breves and Bagre municipalities, in July and August 2007, to identify risk factors of transmission and to recommend preventative measures. Of the 25 cases identified in both cohorts, 13 (52%) were men, and the most frequent symptoms were fever (96%),asthenia (80%), myalgia (76%), abdominal pain (64%), retro-orbital pain, headaches and asthma (52%). We recommend detailed investigation of future outbreaks and other studies to better understand and control oral transmission of T. cruzi.

Entities:  

Mesh:

Year:  2009        PMID: 19762577     DOI: 10.1258/td.2009.090035

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  19 in total

1.  Trypanosoma cruzi highjacks TrkC to enter cardiomyocytes and cardiac fibroblasts while exploiting TrkA for cardioprotection against oxidative stress.

Authors:  Daniel Aridgides; Ryan Salvador; Mercio PereiraPerrin
Journal:  Cell Microbiol       Date:  2013-03-14       Impact factor: 3.715

Review 2.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

3.  Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection.

Authors:  Christopher S Eickhoff; Olivia K Giddings; Nobuko Yoshida; Daniel F Hoft
Journal:  Mem Inst Oswaldo Cruz       Date:  2010-08       Impact factor: 2.743

Review 4.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 5.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

6.  Induction of proinflammatory cytokines and nitric oxide by Trypanosoma cruzi in renal cells.

Authors:  Gabriel M de Oliveira; Nobuko Yoshida; Elisa M S Higa; Sérgio Shenkman; Monique Alves; Daniela Staquicini; Cynthia Cascabulho; Nestor Schor
Journal:  Parasitol Res       Date:  2011-02-17       Impact factor: 2.289

Review 7.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

8.  Chagas disease: "the new HIV/AIDS of the Americas".

Authors:  Peter J Hotez; Eric Dumonteil; Laila Woc-Colburn; Jose A Serpa; Sarah Bezek; Morven S Edwards; Camden J Hallmark; Laura W Musselwhite; Benjamin J Flink; Maria Elena Bottazzi
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

9.  Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFβ signaling.

Authors:  Junko Matsuoka; Masakazu Yashiro; Yosuke Doi; Yuhiko Fuyuhiro; Yukihiro Kato; Osamu Shinto; Satoru Noda; Shinichiro Kashiwagi; Naoki Aomatsu; Toshiki Hirakawa; Tsuyoshi Hasegawa; Kiyoshi Shimizu; Toshiyuki Shimizu; Atsushi Miwa; Nobuya Yamada; Tetsuji Sawada; Kosei Hirakawa
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

10.  Structural basis of the interaction of a Trypanosoma cruzi surface molecule implicated in oral infection with host cells and gastric mucin.

Authors:  Cristian Cortez; Nobuko Yoshida; Diana Bahia; Tiago J P Sobreira
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.